UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000005904
Receipt No. R000006983
Scientific Title Multicenter Clinical Study on the Safety and Efficacy of Nilotinib Discontinuation in Patients with Chronic Myelogenous Leukemia-Chronic Phase and Complete Molecular Response
Date of disclosure of the study information 2011/07/01
Last modified on 2018/11/07 15:18:00

No. Disposal Last modified on Item of update
1 Insert 2011/07/01 21:26:16
2 Update 2012/01/10 20:49:10 TEL
Institute
Institute
Organization
Organization
Category of Funding Organization
Tel1
3 Update 2012/01/10 20:50:55 Key inclusion criteria
Key inclusion criteria
4 Update 2012/07/02 14:54:55 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results
Results
5 Update 2012/07/02 15:03:42 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results
Results
6 Update 2012/07/02 15:11:51 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
7 Update 2013/01/01 14:29:48 Recruitment status
8 Update 2014/01/01 12:07:58 TEL
Email
TEL
Email
9 Update 2014/10/27 22:25:51 Last name of lead principal investigator
Last name of lead principal investigator
TEL
Email
10 Update 2014/10/27 22:49:11 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
11 Update 2016/02/24 11:12:06 Institute
Institute
12 Update 2018/09/12 18:01:34 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results
13 Update 2018/11/07 15:15:17 Date of closure to data entry
Date trial data considered complete
Date analysis concluded
URL related to results and publications
Results
14 Update 2018/11/07 15:18:00 Name of primary sponsor
Organization


Contact us.